Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Veerle Kersemans

Awards & Distinctions

18 Results

2008

The use of [I-123]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: In vitro R1M rabdomyosarcoma cell and in vivo mouse experiments

Veerle KersemansValentijn VergoteVirginie de GelderIndira MadaniHubert ThierensWilfried De NeveJ MERTENSGuido SlegersChristian Paul G. BurvenichKathelijne Peremans et al.

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

2007

Use of [I-121]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma

Kathelijne PeremansVeerle KersemansTiziana LiutiEva VandermeulenBart CornelissenIngrid GielenBart De SpiegeleerJ MERTENSChristian Paul G. BurvenichGuido Slegers

A1 Journal Article in VETERINARY RADIOLOGY & ULTRASOUND

2006

Comparative biodistribution study of the new tumor tracer [I-123]-2-iodo-L-phenylalanine with [I-123]-2-iodo-L-tyrosine

Veerle KersemansBart CornelissenK KERSEMANSRudi DierckxBart De SpiegeleerJ MERTENSGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

I-123/125-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice

Veerle KersemansBart CornelissenK KERSEMANSM BAUWENSRudi DierckxBart De SpiegeleerJ MERTENSGuido Slegers

A1 Journal Article in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Influence of sedation and data acquisition method on tracer uptake in animal models: [I-123]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice

Veerle KersemansBart De SpiegeleerJ MERTENSGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.

Veerle KersemansK KERSEMANSBart CornelissenLudovicus StaelensBart De SpiegeleerJ MERTENSGuido Slegers

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents

Ruth OltenfreiterLudovicus StaelensVeerle KersemansBart CornelissenF FRANKENNEJM FOIDARTChristophe Van De WieleGuido Slegers

A1 Journal Article in APPLIED RADIATION AND ISOTOPES

2005

Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice

Bart CornelissenVeerle KersemansLennart JansLudovicus StaelensRuth OltenfreiterT ThonissenEric AchtenGuido Slegers

A1 Journal Article in BRITISH JOURNAL OF RADIOLOGY

In vitro and in vivo evaluation of [I-123]-VEGF(165) as a potential tumor marker

Bart CornelissenRuth OltenfreiterVeerle KersemansLudovicus StaelensF FRANKENNEJM FOIDARTG SLEGERS

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy

Bart CornelissenC LAHORTEVeerle KersemansG CAPRIOTTIE BONANNOA SIGNOREChristophe Van De WieleRudi DierckxGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

In vivo evaluation and dosimetry of I-123-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT in an R1M rhabdomyrosarcoma athymic mouse model

Veerle KersemansBart CornelissenKlaus BacherK KERSEMANSHubert ThierensRudi DierckxBart De SpiegeleerGuido SlegersJ MERTENS

A1 Journal Article in JOURNAL OF NUCLEAR MEDICINE

In vivo evaluation of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno [3,4-c]pyridin-5-one: a presumed dopamine D-4 receptor ligand for SPECT studies

Ludovicus StaelensRuth OltenfreiterPETER BLANCKAERTVeerle KersemansKATIA VANDENBULCKEChristophe Van De WieleGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

Nuclear medicine in oncology

Kathelijne PeremansVeerle KersemansTim BosmansHenri van BreeChristophe Van De Wiele

A1 Journal Article in VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of Tc-99m labelled epidermal growth factor

Bart CornelissenVeerle KersemansIngrid BurvenichRuth OltenfreiterJL VANDERHEYDENO BOERMANC VANDEWIELEGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE COMMUNICATIONS

Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents

Ruth OltenfreiterLudovicus StaelensS LABIEDVeerle KersemansF FRANKENNEA NOELChristophe Van De WieleGuido Slegers

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

2004

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction

Bart CornelissenKatrien RemautVeerle KersemansRuth OltenfreiterIngrid BurvenichGuido Slegers

2003

Biodistribution og 123/125I-VEGF in wild type NMRI and A2058 tumor inoculated athymic mice

Bart CornelissenA JanssensVeerle KersemansRuth OltenfreiterRudi DierckxGuido Slegers

Synthesis and in vivo evaluation in mice and rabbits of [123I]-3-(4-iodobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one as possible agent for imaging of the dopamine D4-receptor

Ludovicus StaelensRuth OltenfreiterFilip DumontVeerle KersemansBart CornelissenGuido Slegers